Cargando…

A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy

We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillusspecies. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugahara, Kaho, Yanagihara, Toyoshi, Nakamura, Yuri, Nakayama, Yuuka, Hanaoka, Katsuzo, Ohgushi, Migiwa, Ogo, Naruhiko, Inutsuka, Yu, Asoh, Tatsuma, Harada, Yukiko, Yoneda, Reiko, Maeyama, Takashige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668043/
https://www.ncbi.nlm.nih.gov/pubmed/34934596
http://dx.doi.org/10.7759/cureus.20333
_version_ 1784614486805577728
author Sugahara, Kaho
Yanagihara, Toyoshi
Nakamura, Yuri
Nakayama, Yuuka
Hanaoka, Katsuzo
Ohgushi, Migiwa
Ogo, Naruhiko
Inutsuka, Yu
Asoh, Tatsuma
Harada, Yukiko
Yoneda, Reiko
Maeyama, Takashige
author_facet Sugahara, Kaho
Yanagihara, Toyoshi
Nakamura, Yuri
Nakayama, Yuuka
Hanaoka, Katsuzo
Ohgushi, Migiwa
Ogo, Naruhiko
Inutsuka, Yu
Asoh, Tatsuma
Harada, Yukiko
Yoneda, Reiko
Maeyama, Takashige
author_sort Sugahara, Kaho
collection PubMed
description We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillusspecies. Since antibiotic treatment alone failed to resolve the infection, percutaneous drainage of the infected bulla was performed. Although a prolonged treatment period was necessary, the infected lung bulla and the lung abscess were eventually resolved. During her illness, the patient also developed arthritis, possibly related to the HTLV-1 infection. Thus, persons infected with HTLV-1 can develop refractory infections, myelopathy, and arthritis. Percutaneous drainage is an option to treat refractory infected lung bullae.
format Online
Article
Text
id pubmed-8668043
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86680432021-12-20 A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy Sugahara, Kaho Yanagihara, Toyoshi Nakamura, Yuri Nakayama, Yuuka Hanaoka, Katsuzo Ohgushi, Migiwa Ogo, Naruhiko Inutsuka, Yu Asoh, Tatsuma Harada, Yukiko Yoneda, Reiko Maeyama, Takashige Cureus Allergy/Immunology We present a case of a 54-year-old Japanese woman with established human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy who developed a refractory infected lung bulla and lung abscess caused by Pseudomonas aeruginosa, Methicillin-resistant Staphylococcus aureus, and Aspergillusspecies. Since antibiotic treatment alone failed to resolve the infection, percutaneous drainage of the infected bulla was performed. Although a prolonged treatment period was necessary, the infected lung bulla and the lung abscess were eventually resolved. During her illness, the patient also developed arthritis, possibly related to the HTLV-1 infection. Thus, persons infected with HTLV-1 can develop refractory infections, myelopathy, and arthritis. Percutaneous drainage is an option to treat refractory infected lung bullae. Cureus 2021-12-10 /pmc/articles/PMC8668043/ /pubmed/34934596 http://dx.doi.org/10.7759/cureus.20333 Text en Copyright © 2021, Sugahara et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Allergy/Immunology
Sugahara, Kaho
Yanagihara, Toyoshi
Nakamura, Yuri
Nakayama, Yuuka
Hanaoka, Katsuzo
Ohgushi, Migiwa
Ogo, Naruhiko
Inutsuka, Yu
Asoh, Tatsuma
Harada, Yukiko
Yoneda, Reiko
Maeyama, Takashige
A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
title A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
title_full A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
title_fullStr A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
title_full_unstemmed A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
title_short A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
title_sort refractory, infected lung bulla and an abscess treated using percutaneous drainage in a patient with human t-lymphotropic virus type 1-associated myelopathy
topic Allergy/Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668043/
https://www.ncbi.nlm.nih.gov/pubmed/34934596
http://dx.doi.org/10.7759/cureus.20333
work_keys_str_mv AT sugaharakaho arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT yanagiharatoyoshi arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT nakamurayuri arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT nakayamayuuka arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT hanaokakatsuzo arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT ohgushimigiwa arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT ogonaruhiko arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT inutsukayu arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT asohtatsuma arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT haradayukiko arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT yonedareiko arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT maeyamatakashige arefractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT sugaharakaho refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT yanagiharatoyoshi refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT nakamurayuri refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT nakayamayuuka refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT hanaokakatsuzo refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT ohgushimigiwa refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT ogonaruhiko refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT inutsukayu refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT asohtatsuma refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT haradayukiko refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT yonedareiko refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy
AT maeyamatakashige refractoryinfectedlungbullaandanabscesstreatedusingpercutaneousdrainageinapatientwithhumantlymphotropicvirustype1associatedmyelopathy